RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
This Quarter Return
-7.23%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$5.58B
AUM Growth
+$5.58B
(+1.5%)
Cap. Flow
+$485M
Cap. Flow
% of AUM
8.69%
Top 10 Holdings %
Top 10 Hldgs %
58.92%
Holding
81
New
11
Increased
25
Reduced
9
Closed
13
Top Buys
| 1 |
FTAI Aviation
FTAI
|
$294M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$131M |
| 3 |
Vistra
VST
|
$111M |
| 4 |
Mercury Insurance
MCY
|
$102M |
| 5 |
New Fortress Energy
NFE
|
$77.6M |
Top Sells
| 1 |
Viatris
VTRS
|
$251M |
| 2 |
United Airlines
UAL
|
$96.7M |
| 3 |
Fluor
FLR
|
$65.3M |
| 4 |
Delta Air Lines
DAL
|
$49M |
| 5 |
PARA
Paramount Global Class B
PARA
|
$48.5M |
Sector Composition
| 1 | Healthcare | 37.06% |
| 2 | Utilities | 27.45% |
| 3 | Energy | 10.46% |
| 4 | Financials | 7.97% |
| 5 | Technology | 6.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TLN
1
Talen Energy Corporation Common Stock
TLN
$17.3B
| $1.22B | 21.91% | 6,123,500 | – | – |
|
|
2
Teva Pharmaceuticals
TEVA
$21.1B
| $393M | 7.04% | 25,550,000 +8,550,000 | +50% | +$131M |
|
3
Golar LNG
GLNG
$4.48B
| $341M | 6.11% | 8,975,149 +1,264,938 | +16% | +$48.1M |
|
|
4
FTAI Aviation
FTAI
$15.8B
| $294M | 5.26% | +2,645,000 | New | +$294M |
|
5
QuidelOrtho
QDEL
$1.95B
| $215M | 3.85% | 6,140,000 +590,000 | +11% | +$20.6M |
|
|
6
New Fortress Energy
NFE
$675M
| $202M | 3.62% | 24,338,675 +9,338,675 | +62% | +$77.6M |
|
7
Roivant Sciences
ROIV
$8.15B
| $179M | 3.21% | 17,767,076 -2,232,924 | -11% | -$22.5M |
|
8
Arcutis Biotherapeutics
ARQT
$1.86B
| $172M | 3.07% | 10,966,672 | – | – |
|
9
BGC Group
BGC
$4.65B
| $158M | 2.83% | 17,226,380 +250,000 | +1% | +$2.29M |
|
10
TransAlta
TAC
$3.65B
| $112M | 2.01% | 12,000,000 +4,387,337 | +58% | +$41M |
|
|
11
Vistra
VST
$64.1B
| $111M | 1.99% | +945,969 | New | +$111M |
|
12
Mr. Cooper
COOP
$12.1B
| $110M | 1.98% | 921,537 -146,143 | -14% | -$17.5M |
|
13
Alight
ALIT
$2.05B
| $105M | 1.88% | 17,720,813 +6,074,134 | +52% | +$36M |
|
14
Integra LifeSciences
IART
$1.18B
| $102M | 1.83% | 4,643,672 +2,025,331 | +77% | +$44.5M |
|
|
15
Mercury Insurance
MCY
$4.28B
| $102M | 1.83% | +1,821,783 | New | +$102M |
|
16
Adaptive Biotechnologies
ADPT
$2.01B
| $97.5M | 1.75% | 13,117,851 -1,482,149 | -10% | -$11M |
|
17
Schrodinger
SDGR
$1.44B
| $94.8M | 1.7% | 4,800,000 -200,000 | -4% | -$3.95M |
|
18
Amneal Pharmaceuticals
AMRX
$3B
| $90M | 1.61% | 10,735,977 +14,199 | +0.1% | +$119K |
|
19
Collegium Pharmaceutical
COLL
$1.22B
| $89.6M | 1.6% | 3,000,000 +650,000 | +28% | +$19.4M |
|
20
ReNew
RNW
$2.76B
| $85.6M | 1.53% | 14,527,412 | – | – |
|
21
Opko Health
OPK
$1.1B
| $80.9M | 1.45% | 48,706,640 | – | – |
|
22
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $75.1M | 1.35% | 3,383,239 +764,136 | +29% | +$17M |
|
|
FLG
23
Flagstar Financial, Inc.
FLG
$5.33B
| $74.7M | 1.34% | +6,425,000 | New | +$74.7M |
|
24
Liberty Global Class A
LBTYA
$4B
| $69.1M | 1.24% | 6,002,651 -592,788 | -9% | -$6.82M |
|
25
Stratasys
SSYS
$906M
| $64.6M | 1.16% | 6,597,333 +406,333 | +7% | +$3.98M |
|